Prevalence, incidence, and risk of cancers in patients with acromegaly: review
Acromegaly is a relatively rare disease, with the incidence of 0.2 - 1.1 cases in 100 000 people per year. Increased secretion of growth hormone (GH) is the main pathomechanism. GH stimulates the liver to the insulin-like growth factor type 1 (IGF-1) production. It leads to the tissues overgrowth,...
Main Authors: | Katarzyna Laszczak, Sylwiusz Niedobylski, Konrad Warchoł, Maciej Dobosz, Olaf Pachciński |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2022-04-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/38099 |
Similar Items
-
Cardiovascular comorbidities in acromegaly
by: Katarzyna Laszczak, et al.
Published: (2021-08-01) -
Health-Related Complications of Acromegaly—Risk of Malignant Neoplasms
by: Marek Ruchala, et al.
Published: (2019-04-01) -
Acromegaly and thyroid cancer: analysis of evolution in a series of patients
by: Karina Danilowicz, et al.
Published: (2020-11-01) -
The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly
by: Mustafa Demirpençe, et al.
Published: (2020-01-01) -
Colonic Cancer and Acromegaly
by: Dorota Dworakowska, et al.
Published: (2019-06-01)